Meglumine antimoniate belongs to the group of medicines called antiprotozoals. Meglumine antimoniate is used to treat an infection called leishmaniasis (Bay sore or chiclero ulcer, espundia, kala-azar or black sickness, Oriental sore, ulcera de Bejuco, uta), that is caused by protozoa (tiny, one-celled organisms). It is grouped under the following drug class(es): Leishmaniasis agents. Its therapeutic use is listed as antiparasitics and antiprotozoals. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include N-Methylglucamine antimonate, Protostib and Glucantim. Its PubChem CID is 64953.
Meglumine antimoniate
| CAS No | 133-51-7 |
|---|---|
| Molecular Formula | C7H18NO8Sb |
| Molecular Weight | 365.98 g/mol |
| Synonyms | hydroxy(dioxo)-λ5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Meglumine antimoniate belongs to the group of medicines called antiprotozoals. Meglumine antimoniate is used to treat an infection called leishmaniasis (Bay sore or chiclero ulcer, espundia, kala-azar or black sickness, Oriental sore, ulcera de Bejuco, uta), that is caused by protozoa (tiny, one-celled organisms).
The listed CAS number is 133-51-7.
The listed molecular formula is C7H18NO8Sb.
The listed molecular weight is 365.98 g/mol.
hydroxy(dioxo)-λ5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol.
The source lists N-Methylglucamine antimonate, Protostib and Glucantim.